1. Minimal residual disease by flow cytometry and allelic‐specific oligonucleotide real‐time quantitative polymerase chain reaction in patients with myeloma receiving lenalidomide maintenance: A pooled analysis. Issue 5 (18th December 2018) Authors: Gambella, Manuela; Omedé, Paola; Spada, Stefano; Muccio, Vittorio Emanuele; Gilestro, Milena; Saraci, Elona; Grammatico, Sara; Larocca, Alessandra; Conticello, Concetta; Bernardini, Annalisa; Gamberi, Barbara; Troia, Rossella; Liberati, Anna Marina; Offidani, Massimo; Rocci, Alberto; Palumbo, Ant... Journal: Cancer Issue: Volume 125:Issue 5(2019) Page Start: 750 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Continuous therapy in standard- and high-risk newly-diagnosed multiple myeloma: A pooled analysis of 2 phase III trials. (December 2018) Authors: D'Agostino, Mattia; De Paoli, Lorenzo; Conticello, Concetta; Offidani, Massimo; Ria, Roberto; Petrucci, Maria Teresa; Spada, Stefano; Marcatti, Magda; Catalano, Lucio; Gilestro, Milena; Guglielmelli, Tommasina; Baldini, Luca; Gamberi, Barbara; Rizzi, Rita; De Sabbata, Giovanni; Di Renzo, Nicola; ... Journal: Critical reviews in oncology/hematology Issue: Volume 132(2018) Page Start: 9 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Serum free light chains and multiple myeloma: Is it time to extend their application?. Issue 4 (6th March 2020) Authors: Markovic, Uros; Leotta, Valerio; Tibullo, Daniele; Giubbolini, Rachele; Romano, Alessandra; Del Fabro, Vittorio; Parrinello, Nunziatina Laura; Cannizzaro, Maria Teresa; Di Raimondo, Francesco; Conticello, Concetta Journal: Clinical case reports Issue: Volume 8:Issue 4(2020) Page Start: 617 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Plerixafor on-demand in association with low-dose cyclophosphamide and G-CSF in the mobilization of patients with multiple myeloma: High effectiveness, low toxicity, and affordable cost. (2020) Authors: Milone, Giuseppe; Conticello, Concetta; Leotta, Salvatore; Michieli, Maria Grazia; Martino, Massimo; Marco, Anna Lia Di; Spadaro, Andrea; Cupri, Alessandra; Condorelli, Annalisa; Milone, Giulio Antonio; Markovic, Uros; Sciortino, Roberta; Schininà, Giovanni; Moschetti, Gaetano; Villari, Loredana;... Journal: Leukemia research reports Issue: Volume 14(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Adjusted comparison between elotuzumab and carfilzomib in combination with lenalidomide and dexamethasone as salvage therapy for multiple myeloma patients. (9th November 2021) Authors: Morabito, Fortunato; Zamagni, Elena; Conticello, Concetta; Pavone, Vincenzo; Palmieri, Salvatore; Bringhen, Sara; Galli, Monica; Mangiacavalli, Silvia; Derudas, Daniele; Rossi, Elena; Ria, Roberto; Catalano, Lucio; Tacchetti, Paola; Mele, Giuseppe; Donatella Vincelli, Iolanda; Antonia Martino, En... Journal: European journal of haematology Issue: Volume 108:Number 3(2022) Page Start: 178 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Pomalidomide: when expectations are understated. (February 2017) Authors: Di Raimondo, Francesco; Conticello, Concetta Journal: Future oncology Issue: Volume 13(2017)Supplement 5 Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Pomalidomide experience: an effective therapeutic approach with immunomodulatory drugs in a patient with relapsed-refractory multiple myeloma. (February 2017) Authors: Conticello, Concetta; Parisi, Marina; Romano, Alessandra; Calafiore, Valeria; Ancora, Flavia; La Fauci, Alessia; Consoli, Maria Letizia; Di Raimondo, Francesco Journal: Future oncology Issue: Volume 13(2017)Supplement 5 Page Start: 3 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Elotuzumab plus lenalidomide and dexamethasone in relapsed/refractory multiple myeloma: Extended 3‐year follow‐up of a multicenter, retrospective clinical experience with 319 cases outside of controlled clinical trials. Issue 4 (1st June 2022) Authors: Bruzzese, Antonella; Derudas, Daniele; Galli, Monica; Martino, Enrica Antonia; Rocco, Stefano; Conticello, Concetta; Califano, Catello; Giuliani, Nicola; Mangiacavalli, Silvia; Farina, Giuliana; Lombardo, Alessandra; Brunori, Marino; Rossi, Elena; Antonioli, Elisabetta; Ria, Roberto; Zambello, Re... Journal: Hematological oncology Issue: Volume 40:Issue 4(2022) Page Start: 704 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Network meta‐analysis of randomized trials in multiple myeloma: Efficacy and safety in frontline therapy for patients not eligible for transplant. Issue 5 (11th July 2022) Authors: Botta, Cirino; Gigliotta, Emilia; Paiva, Bruno; Anselmo, Rita; Santoro, Marco; Otero, Paula Rodriguez; Carlisi, Melania; Conticello, Concetta; Romano, Alessandra; Solimando, Antonio Giovanni; Cerchione, Claudio; Vià, Matteo Da; Bolli, Niccolò; Correale, Pierpaolo; Di Raimondo, Francesco; Gentile,... Journal: Hematological oncology Issue: Volume 40:Issue 5(2022) Page Start: 987 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Diagnostic framing of IgM monoclonal gammopathy: Focus on Waldenström macroglobulinemia. Issue 2 (7th September 2018) Authors: Tedeschi, Alessandra; Conticello, Concetta; Rizzi, Rita; Benevolo, Giulia; Laurenti, Luca; Petrucci, Maria Teresa; Zaja, Francesco; Varettoni, Marzia Journal: Hematological oncology Issue: Volume 37:Issue 2(2019) Page Start: 117 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗